HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo
Authors
Keywords
Neutrophils, Inflammation, Macrophages, Apoptosis, Inflammatory diseases, Lung and intrathoracic tumors, Cell enumeration techniques, Viable cell counting
Journal
PLoS One
Volume 10, Issue 1, Pages e0114975
Publisher
Public Library of Science (PLoS)
Online
2015-01-24
DOI
10.1371/journal.pone.0114975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
- (2014) Komal Jhaveri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling
- (2014) Desiree Anthony et al. FASEB JOURNAL
- Novel Mechanism of Attenuation of LPS-Induced NF-κB Activation by the Heat Shock Protein 90 Inhibitor, 17-N-allylamino-17-demethoxygeldanamycin, in Human Lung Microvascular Endothelial Cells
- (2013) Gagan S. Thangjam et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
- (2013) N. Miyajima et al. CANCER RESEARCH
- A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non-Small Cell Lung Cancer
- (2013) M. A. Socinski et al. CLINICAL CANCER RESEARCH
- HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer
- (2013) C-H Lai et al. ONCOGENE
- Lung cancer: potential targets for immunotherapy
- (2013) Eric Tartour et al. Lancet Respiratory Medicine
- Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer
- (2012) T. Shimamura et al. CLINICAL CANCER RESEARCH
- Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer
- (2012) Michael W. Hance et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
- (2012) J. Acquaviva et al. MOLECULAR CANCER THERAPEUTICS
- Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPD
- (2012) Ross Vlahos et al. PLoS One
- A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors
- (2011) Gopa Iyer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma
- (2011) Andrea E. Wahner Hendrickson et al. GYNECOLOGIC ONCOLOGY
- Fibroblast Growth Factor Receptor 3 (FGFR3) Is a Strong Heat Shock Protein 90 (Hsp90) Client
- (2011) Melanie B. Laederich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
- (2011) W. Ying et al. MOLECULAR CANCER THERAPEUTICS
- Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling
- (2011) David A. Proia et al. PLoS One
- Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1
- (2011) Ben A. Croker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits
- (2010) Dimitris Stellas et al. BMC CELL BIOLOGY
- Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis
- (2010) Julio Madrigal-Matute et al. CARDIOVASCULAR RESEARCH
- Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
- (2010) James R Porter et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- EC144, a Synthetic Inhibitor of Heat Shock Protein 90, Blocks Innate and Adaptive Immune Responses in Models of Inflammation and Autoimmunity
- (2010) T. J. Yun et al. JOURNAL OF IMMUNOLOGY
- Neutrophils Require SHP1 To Regulate IL-1 Production and Prevent Inflammatory Skin Disease
- (2010) B. A. Croker et al. JOURNAL OF IMMUNOLOGY
- HSP90 at the hub of protein homeostasis: emerging mechanistic insights
- (2010) Mikko Taipale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
- (2009) Bénédicte Cauwe et al. Integrative Biology
- Neutrophils Ameliorate Lung Injury and the Development of Severe Disease during Influenza Infection
- (2009) M. D. Tate et al. JOURNAL OF IMMUNOLOGY
- Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis
- (2008) John W. Rice et al. ARTHRITIS AND RHEUMATISM
- Innate immunity meets with cellular stress at the IKK complex: Regulation of the IKK complex by HSP70 and HSP90
- (2008) Antero Salminen et al. IMMUNOLOGY LETTERS
- Epidermal Growth Factor Receptor Signaling to Erk1/2 and STATs Control the Intensity of the Epithelial Inflammatory Responses to Rhinovirus Infection
- (2008) Kenneth Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now